These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 317467)

  • 1. The assay of prekallikrein activator in human blood products.
    Snape TJ; Griffith D; Vallet L; Wesley ED
    Dev Biol Stand; 1979; 44():115-20. PubMed ID: 317467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro assay for prekallikrein activator (PKA).
    Lundblad JL
    Dev Biol Stand; 1979; 44():107-14. PubMed ID: 317466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation of a prekallikrein concentrate and determination of its activator in blood derivatives].
    Simonianová E
    Cesk Farm; 1992 Feb; 41(1):8-9. PubMed ID: 1586974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An optimized assay for prekallikrein activator activity in human plasma products.
    Tölö H; Suomela H
    Thromb Res; 1982 Jul; 27(1):35-44. PubMed ID: 6981866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prekallikrein activator levels and side effects with human albumin preparations.
    Lüben G; Quast U; Geiger H
    Dev Biol Stand; 1980; 48():123-7. PubMed ID: 6974110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma kallikrein and prekallikrein activator (PKA) activities in various preparations of human immunoglobulins and albumins].
    Kawiak J; Aleksandrowicz J; Kawalec M; Drozdz M
    Med Dosw Mikrobiol; 1987; 39(3):203-7. PubMed ID: 3499549
    [No Abstract]   [Full Text] [Related]  

  • 8. Standardization of prekallikrein activator (PKA): the 1st British reference preparation for PKA.
    Kerry PJ; Curtis AD; Paton CJ; Thomas DP
    Br J Haematol; 1982 Oct; 52(2):275-81. PubMed ID: 6982063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a bradykinin-generating hypotensive substance in plasma protein fraction: prekallikrein activator (PKA-beta-Xiia).
    Bakker JC; de Vries-van Rossen A; Radema H; Bleeker W; Ufkes JG; van Rosevelt RF; van Mourik JA
    Adv Exp Med Biol; 1983; 156 (Pt B)():1091-7. PubMed ID: 6602466
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
    Alving BM; Tankersley DL; Mason BL
    J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymes of the contact phase of blood coagulation: kinetics with various chromogenic substrates and a two-substrate assay for the joint estimation of plasma prekallikrein and factor XI.
    Retzios AD; Rosenfeld R; Schiffman S
    J Lab Clin Med; 1988 Nov; 112(5):560-6. PubMed ID: 3263454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypotensive effect of prekallikrein activator (PKA) in plasma protein fraction (PPF).
    Heinonen J; Peltola K; Himberg JJ; Suomela H
    Dev Biol Stand; 1980; 48():129-30. PubMed ID: 7024018
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of plasma prekallikrein using beta-XIIa (Hageman factor fragment)].
    Komiyama Y; Egawa H; Murata K
    Rinsho Byori; 1984 May; 32(5):558-62. PubMed ID: 6332927
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of a microassay for human plasma prekallikrein.
    De La Cadena RA; Scott CF; Colman RW
    J Lab Clin Med; 1987 May; 109(5):601-7. PubMed ID: 3646287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of guinea-pig plasma prekallikrein. Activation by prekallikrein activator derived from guinea-pig skin.
    Yamamoto T; Kozono K; Okamoto T; Kato H; Kambara T
    Biochim Biophys Acta; 1980 Aug; 614(2):511-25. PubMed ID: 6967737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of prekallikrein activator (PKA) activity in plasma-derived preparations].
    Miks B; Aleksandrowicz J; Kawiak J
    Med Dosw Mikrobiol; 1990; 42(3-4):171-7. PubMed ID: 2128105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of activation of prekallikrein by prekallikrein activator.
    Tankersley DL; Fournel MA; Schroeder DD
    Biochemistry; 1980 Jul; 19(14):3121-7. PubMed ID: 6967731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction.
    Alving BM; Hojima Y; Pisano JJ; Mason BL; Buckingham RE; Mozen MM; Finlayson JS
    N Engl J Med; 1978 Jul; 299(2):66-70. PubMed ID: 661863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human plasma prekallikrein. Immunoaffinity purification and activation to alpha- and beta-kallikrein.
    Burger D; Schleuning WD; Schapira M
    J Biol Chem; 1986 Jan; 261(1):324-7. PubMed ID: 2416749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.